Results: A total of 695 patients were enrolled into this study. The clopidogrel-rivaroxaban combination significantly reduced the risk of composite outcome (HR: 0.59, 95%CI: 0.41–0.83) without ...

Objective After transcatheter aortic valve implantation (TAVI), the optimal regimen of anticoagulant therapy in patients with an additional indication for oral anticoagulation remains a matter of ...

Bivalirudin had outperformed UFH (without glycoprotein IIb/IIIa) in a few trials, but pretreatment with clopidogrel was not routinely accomplished in these trials. This randomized trial sought to ...

This finding is consistent with prior anticoagulant studies in ischemic stroke ... (Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke) and CHANCE (Clopidogrel in High-Risk Patients ...